Agreed Polaco, the biggest bang for the buck would arguably be for someone to buy ADXS now when it's dirt cheap. If they wait until after the Phase 3 is finished they will pay a lot more. Someone could scoop up the entire company now for around $25pps/$1 billion market cap or less. IMO the proof of concept has already been shown in the "best ever" GOG Phase 2 trial results. I don't think we'll get bought out this year but I expect to see a major licensing deal with Astra Zeneca struck.